BackJasper Therapeutics- Units (1 Ord Class A & 1/2 War) Overview
Jasper Therapeutics Inc - Units (1 Ord Class A & 1/2 War)

Jasper Therapeutics- Units (1 Ord Class A & 1/2 War) Return on Equity

Valuation check: AMHCU's ROE is -2165.39%, below the sector sector average of 11.67%.

Get informed when a big investor buys or sells

+ Follow

ROE

-2165.39%

Return on Equity

-2165.39%

Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.

ROE (Comparison Companies)

Loading

ROE History

Loading

ROE Comparison

Loading

Jasper Therapeutics- Units (1 Ord Class A & 1/2 War) (AMHCU) FAQ

Jasper Therapeutics- Units (1 Ord Class A & 1/2 War) posts a ROE of -2165.39%. That is below the sector sector average of 11.67%. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

For its sector stocks, a ROE near 11.67% is typical. Jasper Therapeutics- Units (1 Ord Class A & 1/2 War)'s -2165.39% is lower that level. That is roughly 18661.9% below the sector mean. Whether that is a warning or an opportunity depends on growth outlook and other fundamentals shown elsewhere on Stockcircle.

Jasper Therapeutics- Units (1 Ord Class A & 1/2 War)'s ROE moves when the underlying profit, equity, or asset base changes. Cost cuts, pricing power, buybacks, write-downs, and cyclical swings can all shift the percentage. The latest reading is -2165.39%; use YoY and peer views to separate noise from signal.

Context for AMHCU's ROE usually means three checks: (1) trend versus prior periods, (2) level versus peers (average 11.67%), and (3) consistency with growth and profitability. This page covers the first two; Jasper Therapeutics- Units (1 Ord Class A & 1/2 War)'s other metric pages and overview cover the third.